GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A

GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A

SSSE:600771
12.20
CNY
+0.07
(+0.58%)
0.13EPS
109.23P/E
6.93BMarket Cap
Apr 23Next Earn
GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A
SSE:600771
(Shanghai Stock Exchange)

Recent

price

12.20

P/E

ratio

109.23

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
0.67
0.67
0.76
0.78
1.04
1.51
3.09
2.87
3.64
2.84
1.85
2.32
2.31
2.57
2.46
2.82
2.69
Revenue per Share
0.56
0.74
1.04
-0.06
0.11
0.01
0.29
0.12
0.15
0.14
0.02
-0.12
-0.51
0.18
0.15
0.13
0.13
Basic EPS, GAAP
-0.16
-0.24
-0.06
-0.17
-0.16
-0.48
-1.38
-1.3
-1.4
-0.54
-0.21
0.13
0.5
0.43
0.21
0.4
- -
Free Cash Flow per Basic Share
0.01
0.01
0.01
0.01
0.01
0.03
- -
- -
0.08
0.03
0.02
0.04
0.04
0.03
0.01
- -
- -
Dividend per Share
-2.75
-2.12
0.06
0.14
0.25
1.84
3.27
3.3
3.41
3.42
3.49
3.38
2.89
3.06
3.21
3.34
3.39
Book Value per Share
-2.88
-2.22
-0.03
0.06
0.22
1.81
3.22
3.1
3.21
3.22
3.28
3.18
2.69
2.86
3.01
3.16
3.22
Tangible Book Value per Share
343
342
341
342
342
284
280
361
355
424
589
472
490
500
496
485
488
Basic Weighted Avg Shares
230
229
261
268
354
428
866
1,037
1,294
1,203
1,088
1,093
1,131
1,284
1,221
1,369
1,312
Sales/Revenue/Turnover
-18.82
-25.3
-11.92
-17.16
-2.01
2.38
16.35
7.23
12.33
12.1
5.98
-8.18
-14.7
12.22
15.19
10.14
7.78
Operating Margin (%)
26
25
22
10
5
5
7
8
13
32
35
38
39
46
54
48
- -
Depreciation Expense
194
251
356
-20
37
2
81
43
53
59
12
-57
-250
90
74
63
63
Net Income, GAAP
0.22
8.1
0.08
- -
28.68
56.61
23.33
52.56
49.38
24.38
- -
- -
- -
7.49
- -
38.19
13.97
Effective Tax Rate (%)
84.25
109.84
136.42
-7.3
10.35
0.47
9.37
4.18
4.12
4.93
1.08
-5.18
-22.11
7.02
6.1
4.6
4.82
Profit Margin (%)
-954
-1,025
-80
-54
10
552
1,297
1,048
855
826
814
796
707
639
734
847
907
Working Capital
- -
- -
- -
- -
- -
- -
- -
9
9
9
26
70
204
39
34
25
20
LT Debt
-837
-705
51
74
86
737
1,634
1,683
1,725
1,737
1,744
1,685
1,423
1,508
1,591
1,653
1,681
Total Equity
- -
- -
610.41
- -
-4.63
1.49
8.49
2.11
3.3
2.67
- -
- -
- -
6.43
- -
4.74
4.02
Return on Invested Capital (%)
-164.05
-306.61
30,356.87
- -
49.53
-0.76
4.48
2.32
2.93
4.2
- -
- -
- -
5.63
- -
3.8
3.67
Return on Capital (%)
- -
- -
- -
-56.98
55.71
0.51
6.96
2.67
3.22
3.53
0.69
-3.35
-16.25
6.19
4.86
3.94
3.82
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
20
37
22
LT Borrowings
- -
- -
- -
LT Finance Leases
23
22
20
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
489
489
489
Market Capitalization
8,277
6,339
6,926

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,710
1,705
1,577
Cash, Cash Equivalents & STI
411
538
473
Accounts Receivable, Net
291
297
276
Inventories
689
687
707
Total Current Liabilities
778
797
669
Payables & Accruals
- -
- -
- -
ST Debt
20
37
22
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.47%
-0.71%
3.92%
Free Cash Flow
26.73%
31.52%
84.97%
Net Income, GAAP
339.71%
-81.72%
-15.32%
Sales/Revenue/Turnover
15.48%
4.94%
12.11%
Total Cash Common Dividend
140.64%
-19.18%
-69.83%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
343
316
234
328
1,221
2025
417
362
- -
309
1,369
2026
488
336
179
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.08
0.04
0.02
0.01
0.15
2025
0.13
0.03
- -
-0.03
0.13
2026
0.14
0.04
-0.01
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
- -
- -
- -
0.01
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS) manufactures and sells traditional Chinese medicines and health wines; its core products encompass traditional and fine Chinese medicines including Dingkun Dan, Guilingji, Angong Niuhuang Pills, Niuhuang Qingxin Pills, Liuwei Dihuang Wan, Wuji Baifeng Wan, and others offered in forms such as pills, powders, tablets, hard and soft capsules, granules, oral liquids, decoctions, syrups, creams, and tonics, alongside health wines like Flavored Guiling Liquor and Yuanji Brand Guiling Liquor. Founded in 1541 and headquartered in Taiyuan, Shanxi Province, China, with historical roots tracing to Xi'an and Beijing's Qianmen area, the company primarily distributes its products domestically through pharmacies and retail channels while pursuing international expansion into Southeast Asia, Europe, and North America. Recent developments include sustained revenue growth to CNY 1.22 billion in 2024 driven by pharmaceutical sales exceeding CNY 1.13 billion, strategic investments in research and development totaling around CNY 100 million annually to launch over 20 new herbal formulations focused on preventative health, and ongoing enhancements to manufacturing facilities blending traditional methods with modern standards amid a competitive traditional Chinese medicine sector.